Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:1678257rdf:typepubmed:Citationlld:pubmed
pubmed-article:1678257lifeskim:mentionsumls-concept:C0026447lld:lifeskim
pubmed-article:1678257lifeskim:mentionsumls-concept:C0003662lld:lifeskim
pubmed-article:1678257lifeskim:mentionsumls-concept:C0243192lld:lifeskim
pubmed-article:1678257lifeskim:mentionsumls-concept:C1280500lld:lifeskim
pubmed-article:1678257lifeskim:mentionsumls-concept:C2003941lld:lifeskim
pubmed-article:1678257lifeskim:mentionsumls-concept:C0283703lld:lifeskim
pubmed-article:1678257pubmed:issue8lld:pubmed
pubmed-article:1678257pubmed:dateCreated1991-9-6lld:pubmed
pubmed-article:1678257pubmed:abstractTextSelective alpha 2-adrenergic agonists UK14304-18 and B-HT 920 were evaluated in the eyes of cynomolgus monkeys. In normal monkeys, unilateral topical application of 0.3%, 0.5%, or 1% UK14304-18 or B-HT 920 reduced (P less than .05) intraocular pressure bilaterally up to 9.9 +/- 1.2 mm Hg (mean +/- SEM) and 8.4 +/- 1.4 mm Hg in treated and contralateral eyes, respectively. Five-day twice-daily 0.5% UK14304-18 administration reduced (P less than .05) intraocular pressure up to 49% in eight glaucomatous monkeys. In eight normal monkeys, 0.5% B-HT 920 and 0.5% UK14304-18 produced no alterations in outflow facility. Following unilateral application of 0.5% B-HT 920 or 0.5% UK14304-18, fluorophotometrically measured aqueous humor production was reduced (P less than .05) bilaterally up to 67% compared with baseline values. Also, 0.5% UK14304-18 reduced (P less than .025) systolic and diastolic blood pressure. UK14304-18 and B-HT 920 seem to reduce intraocular pressure by decreasing aqueous production. They are potential new agents for the treatment of glaucoma.lld:pubmed
pubmed-article:1678257pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:granthttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:languageenglld:pubmed
pubmed-article:1678257pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:citationSubsetAIMlld:pubmed
pubmed-article:1678257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:1678257pubmed:statusMEDLINElld:pubmed
pubmed-article:1678257pubmed:monthAuglld:pubmed
pubmed-article:1678257pubmed:issn0003-9950lld:pubmed
pubmed-article:1678257pubmed:authorpubmed-author:PodosS MSMlld:pubmed
pubmed-article:1678257pubmed:authorpubmed-author:SteidlSSlld:pubmed
pubmed-article:1678257pubmed:authorpubmed-author:MittagT WTWlld:pubmed
pubmed-article:1678257pubmed:authorpubmed-author:WangR FRFlld:pubmed
pubmed-article:1678257pubmed:authorpubmed-author:SerleJ BJBlld:pubmed
pubmed-article:1678257pubmed:issnTypePrintlld:pubmed
pubmed-article:1678257pubmed:volume109lld:pubmed
pubmed-article:1678257pubmed:ownerNLMlld:pubmed
pubmed-article:1678257pubmed:authorsCompleteYlld:pubmed
pubmed-article:1678257pubmed:pagination1158-62lld:pubmed
pubmed-article:1678257pubmed:dateRevised2007-11-14lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:meshHeadingpubmed-meshheading:1678257-...lld:pubmed
pubmed-article:1678257pubmed:year1991lld:pubmed
pubmed-article:1678257pubmed:articleTitleSelective alpha 2-adrenergic agonists B-HT 920 and UK14304-18. Effects on aqueous humor dynamics in monkeys.lld:pubmed
pubmed-article:1678257pubmed:affiliationDepartment of Ophthalmology, Mount Sinai School of Medicine, New York, NY 10029.lld:pubmed
pubmed-article:1678257pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:1678257pubmed:publicationTypeResearch Support, U.S. Gov't, P.H.S.lld:pubmed
pubmed-article:1678257pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed